University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 2N-08-2


 
Description: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of ASA404 in Combination with Paclitaxel and Carboplatin as First-Line Treatment for Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC).
Status: Closed
Randomized? Yes


Researchers  
Principal InvestigatorTitle
Barbara GitlitzM.D.

Data Management
NameTitle
Charlean KetchensR.N.
Lagrimas IlaganD.M.
Gina TseR.N.
Eduardo MejiaD.M.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.